News Roundup: July 17 to July 23
Your weekly roundup of the latest news from Drug Topics®.
Text Message Programs in Pharmacy: Could They be Doing More?
Most pharmacies are now utilizing text message programs for their customers. How can they be fully utilized, and what is the next step?
How Much Power Should You Give Automation in the Front-End of Your Pharmacy?
The world continues to become more automated, but how much responsibility should you give AI within your pharmacy?
What You Need to Know About the Albuterol Shortage
The FDA is working quickly to address shortages of the form used in nebulizers.
Investigating Gastrointestinal Involvement in Post-Acute COVID-19 Syndrome
Investigators found significant associations between GI-PACS and multi-system concomitant symptoms.
Monthly Buprenorphine Initiation Rates Remain Flat, Despite Policy Changes
Only 1 in 5 patients who initiated buprenorphine were retained in therapy for at least 180 days.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
